- AU$272.31m
- AU$1.20bn
- AU$1.37bn
Press Digest: Wall Street Journal - Dec 15
Brief: Healius Acknowledges Australian Competition & Consumer Commission Decision on ACL Takeover
Brief: Australia's ACCC Opposes Australian Clinical Labs' Proposed Acquisition Of Healius Ltd
Brief: Australian Clinical Labs Says It Intends To Withdraw Takeover Offer For Healius
Healius slumps as Australian Clinical Labs withdraws $1 bln takeover offer
Australian Clinical Labs to withdraw its $1 bln offer to buy Healius (updated)
Australian Clinical Labs to withdraw takeover offer for Healius
Australia's competition regulator opposes Australian Clinical Labs' offer to buy Healius
Brief: Australian Retirement Trust Raises Stake In Healius To 11.449%- Exchange Filing
Brief: State Street Corp Becomes Healius' Substantial Holder - Exchange Filing
Morgan Stanley upgrades rating for Aussie pathology firm Healius
Brief: Healius Says Board Has Appointed Non-Executive Director Kate Mckenzie As Interim Chair
Morgan Stanley upgrades stock rating for Australia's Healius
Citi trims PT on Australia's Healius as earnings forecast misses estimates
Australia's Healius sinks as trading resumes after halt
Analysts cut Healius' PT, downgrade on lower earnings estimate
Brief: Australian Clinical Labs Notes Healius' Entitlement Offer Announced On 20 Nov
Jefferies downgrades Healius on subdued healthcare services environment
Brief: Healius Seeks Trading Halt